338 related articles for article (PubMed ID: 8759987)
21. Myasthenia gravis with ocular involvement in older patients.
Weizer JS; Lee AG; Coats DK
Can J Ophthalmol; 2001 Feb; 36(1):26-33. PubMed ID: 11227387
[TBL] [Abstract][Full Text] [Related]
22. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
[TBL] [Abstract][Full Text] [Related]
23. Myasthenia gravis: steroid-induced effects on lymphocyte subpopulations in myasthenia gravis.
Hammarström L; Smith E
Eur Neurol; 1977; 16(1-6):16-22. PubMed ID: 308007
[TBL] [Abstract][Full Text] [Related]
24. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
25. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
[TBL] [Abstract][Full Text] [Related]
26. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
28. Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis.
Johnson S; Katyal N; Narula N; Govindarajan R
Med Sci Monit; 2021 Oct; 27():e933296. PubMed ID: 34707081
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
30. Inferior oblique muscle paresis as a sign of myasthenia gravis.
Almog Y; Ben-David M; Nemet AY
J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
[TBL] [Abstract][Full Text] [Related]
31. Association of myasthenia gravis and Behçet's disease: A case report.
Kisabay A; Sari US; Boyaci R; Batum M; Yilmaz H; Selcuki D
Neurol Neurochir Pol; 2016; 50(4):284-7. PubMed ID: 27375145
[TBL] [Abstract][Full Text] [Related]
32. Quantification of Cover Test Prior and Post Pyridostigmine in Diagnosis of Myasthenia Gravis.
Saint-Gerons M; Rubio MA; Martinez A; Matheu A
J Binocul Vis Ocul Motil; 2021; 71(2):71-76. PubMed ID: 33877951
[No Abstract] [Full Text] [Related]
33. A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.
Di L; Shen F; Wen X; Lu Y; Zhu W; Wang M; Da Y
Front Immunol; 2022; 13():839075. PubMed ID: 35371086
[TBL] [Abstract][Full Text] [Related]
34. Thymectomy in the treatment of ocular myasthenia gravis.
Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
[TBL] [Abstract][Full Text] [Related]
35. Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.
Kanai T; Uzawa A; Kawaguchi N; Oda F; Ozawa Y; Himuro K; Kuwabara S
J Neurol Sci; 2019 Jan; 396():8-11. PubMed ID: 30391823
[TBL] [Abstract][Full Text] [Related]
36. Myasthenia gravis in children: a longitudinal study.
Ashraf VV; Taly AB; Veerendrakumar M; Rao S
Acta Neurol Scand; 2006 Aug; 114(2):119-23. PubMed ID: 16867035
[TBL] [Abstract][Full Text] [Related]
37. [Myasthenia in elderly patients: a series of 23 cases].
Durand F; Camdessanché JP; Jomir L; Antoine JC; Cathébras P
Rev Med Interne; 2005 Dec; 26(12):924-30. PubMed ID: 16229927
[TBL] [Abstract][Full Text] [Related]
38. Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Mantegazza R; O'Brien FL; Yountz M; Howard JF;
Ann Clin Transl Neurol; 2020 Aug; 7(8):1327-1339. PubMed ID: 32700461
[TBL] [Abstract][Full Text] [Related]
39. Medical treatment options for ocular myasthenia gravis.
Antonio-Santos AA; Eggenberger ER
Curr Opin Ophthalmol; 2008 Nov; 19(6):468-78. PubMed ID: 18854691
[TBL] [Abstract][Full Text] [Related]
40. Rituximab in severe seronegative juvenile myasthenia gravis: review of the literature.
Koul R; Al Futaisi A; Abdwani R
Pediatr Neurol; 2012 Sep; 47(3):209-12. PubMed ID: 22883288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
